IP Library › Granted Patent US 8,703,417
Granted Patent B2
US 8,703,417 · App. 13/530,001 · Granted Apr 22, 2014

Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest

Inventors: Christopher Bieniarz (Tucson, AZ); Michael Farrell (Tucson, AZ)
Assignee: Ventana Medical Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,703,417
App. No.
13/530,001
Granted
Apr 22, 2014
Kind
B2
Abstract

The invention is directed to enhanced methods for detecting an analyte of interest in situ, by immunoassay, or by hybridization comprising binding an enzyme-labeled conjugate molecule to an analyte of interest in the presence of a redox-inactive reductive species and a soluble metal ion. The enzyme catalyzes the conversion of the inactive reductive species to an active reducing agent, which in turn reduces the metal ion to a metal atom thereby providing an enhanced means of detecting the analyte via metal deposition.

Claims (23)

1. A kit for detecting an analyte of interest in a biological sample through a localized deposition of metal atoms, the kit comprising a specific binding member for the analyte of interest contained within a first vessel or immobilized on a solid support, a redox-inactive reductive species contained within a second vessel, an enzyme label for rendering the reductive species active contained within a third vessel, a metal ion contained within a fourth vessel, and instructions, wherein the enzyme label is selected from the group consisting of alkaline phosphatase, acid phosphatase, alpha- and beta-galactosidases, alpha- and beta-glucosidases, esterases, and beta-lactamases.

2. The kit of claim 1 wherein the specific binding member is immobilized on a solid support.

3. The kit of claim 1 wherein the metal ion is silver ion.

4. The kit of claim 1 wherein the specific binding member for the analyte of interest is an antibody.

5. The kit of claim 1 wherein the specific binding member for the analyte of interest is an oligonucleotide sequence.

6. The kit of claim 1 wherein the enzyme label is a phosphatase.

7. The kit of claim 1 wherein the enzyme label is alkaline phosphatase.

8. The kit of claim 7 wherein the redox-inactive reductive species is ascorbic acid phosphate.

9. The kit of claim 1 wherein the redox-inactive reductive species is selected from the group consisting of hydroquinone mono- and di-phosphates, naphthohydroquinone mono- and di-phosphates, and anthrahydroquinone mono-, di-phosphates, and derivatives thereof.

10. The kit of claim 1 wherein the redox-inactive reductive species is selected from the group consisting of sesamol phosphate, eugenol phosphate, alpha-tocopherol phosphate, and derivatives thereof.

11. The kit of claim 1 wherein the metal ion is selected from the group consisting of silver ion and gold ion.

12. The kit of claim 1 wherein the metal ion is silver ion.

13. The kit of claim 12 wherein the kit further comprises reagents for metal precipitate development.

14. A kit for detecting an analyte of interest through a localized deposition of metal atoms, comprising

a first reagent including a first member of a specific binding pair,

a second reagent including an enzyme-labeled conjugate, the enzyme-labeled conjugate comprising a second member of the specific binding pair and an enzyme,

a third reagent including a redox-inactive reductive species that is a substrate for the enzyme and soluble metal ions, wherein the redox-inactive species is the substrate for the enzyme so that the enzyme can convert the redox-inactive reductive species into to a redox- active species and the redox-active species can reduce the soluble metal ions to an insoluble metal that precipitates at or about the point where the enzyme-labeled conjugate molecule is bound so as to provide the localized deposition of metal atoms, and

instructions,

wherein the reagents are contained in one or more vessels and the enzyme is selected from the group consisting of alkaline phosphatase, acid phosphatase, alpha- and beta-galactosidases, and esterases.

15. The kit of claim 14 , wherein the second member of the specific binding pair is an antibody.

16. The kit of claim 14 , wherein the enzyme is selected from the group consisting of alkaline phosphatase and acid phosphatase and the redox-inactive reductive species is selected from the group consisting of hydroquinone mono- and di-phosphates, naphthohydroquinone mono- and di-phosphates, and anthrahydroquinone mono- and di-phosphates.

17. The kit of claim 14 , wherein the enzyme is selected from the group consisting of alkaline phosphatase and acid phosphatase and the redox-inactive reductive species is selected from the group consisting of sesamol phosphate, eugenol phosphate and alpha-tocopherol phosphate.

18. The kit of claim 14 , wherein the soluble metal ions are selected from the group consisting of silver ions and gold ions.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2013
From: BIENIARZ, CHRISTOPHER; FARRELL, MICHAEL
To: VENTANA MEDICAL SYSTEMS, INC.
Reel/Frame 029658/0841 →
Continuity (5)
Division 12608261 · Oct 29, 2009
Continuation 11015646 · Dec 20, 2004
Continuation In Part 10877919 · Jun 24, 2004
Provisional Application 60482596 · Jun 24, 2003
Related Publication 20120283141A1 · Nov 8, 2012